Profil
Bernd Schmidt is currently the Chief Technical Officer at Sensorion SA since 2023.
Prior to this, he worked as the Vice President-Product Delivery at Quell Therapeutics Ltd. Mr. Schmidt is a graduate of Friedrich-Alexander University of Erlangen-Nuremberg.
Aktive Positionen von Bernd Schmidt
| Unternehmen | Position | Beginn |
|---|---|---|
| SENSORION | Technik-/Wissenschafts-/F&E-Leiter | 11.12.2023 |
Ehemalige bekannte Positionen von Bernd Schmidt
| Unternehmen | Position | Ende |
|---|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
Ausbildung von Bernd Schmidt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Health Technology |
















